NewAmsterdam Pharma (NAMS) Other Operating Expenses (2025)
NewAmsterdam Pharma (NAMS) posted Other Operating Expenses of -$1000.0 for Q3 2025.
NewAmsterdam Pharma (NAMS) Other Operating Expenses (2025) Analysis & Trends
NewAmsterdam Pharma has reported Other Operating Expenses for 1 years, with the latest figure at -$1000.0 in Q3 2025.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$1000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$1000.0 (changed N/A YoY) and the FY2022 annual result came in at $61.8 million, changed N/A from the prior year.
- Other Operating Expenses held at -$1000.0 in Q3 2025 per NAMS's latest filing.
- Over five years, Other Operating Expenses peaked at -$1000.0 in Q3 2025 and troughed at -$1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | NewAmsterdam Pharma | 3.17 Bn | 3.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,000.00 |